GRI BIO, INC.— Sankey Diagram
Annual mode · period ending 2025-12-31 · SEC EDGAR
FY2023 - Q4(Jan 23 · Feb 23 · Mar 23)
Total Assets
$9M
↑+51.0% +$3Mvs FY2024
Total Liabilities
$3M
↑+55.7% +$951Kvs FY2024
Equity
$6M
↑+49.0% +$2Mvs FY2024
Cash
$8M
↑+63.7% +$3Mvs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $9M | $6M |
| Current Assets | $9M | $6M |
| Cash | $8M | $5M |
| ST Investments | $0 | $0 |
| Receivables | $0 | $0 |
| Inventory | $0 | $0 |
| Other Current | $363K | $587K |
| Non-Current Assets | $74K | $124K |
| PPE | $3K | $4K |
| Goodwill | $0 | $0 |
| Intangibles | $0 | $0 |
| Investments | $0 | $0 |
| Other Non-Current | $71K | $120K |
| Total Liab+Eq | $9M | $6M |
| Current Liab. | $3M | $2M |
| Accounts Payable | $2M | $897K |
| Short-Term Debt | $0 | $0 |
| Deferred Revenue | $0 | $0 |
| Other CL | $806K | $739K |
| Non-Current Liab. | $15K | $71K |
| Long-Term Debt | $0 | $0 |
| Other LT Liab. | $15K | $71K |
| Equity | $6M | $4M |
| Retained Earnings | $52M | $40M |
| Other Equity | $0 | $0 |
QuarterCharts · SEC EDGAR data · GRI · Comparing FY2025 vs FY2024